Obstructive sleep apnea may increase the risk for Parkinson’s disease, but early intervention with continuous positive airway ...

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.

Use of positive airway pressure therapy decreased the risk for all-cause and cardiovascular mortality in adults with ...

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

The global sleep apnea devices market report consists of exclusive data on 39 vendors. The competitive landscape of sleep apnea devices is dynamic, with multiple players vying for market share through ...